Earnings Alerts

Shenzhen Transsion Holdings (688036) Earnings Surpass Estimates: FY R&D Expenses and Dividend Highlights

  • Shenzhen Transsion’s Fiscal Year Research & Development (R&D) expenses came in at 2.26 billion yuan, which is lower than the predicted estimate of 2.51 billion yuan.

  • The company announced a final dividend per share of 3 yuan.

  • The stock currently holds a favorable rating with 22 buy recommendations, 1 hold recommendation, and no sells.


A look at Shenzhen Transsion Holdings Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth4
Resilience5
Momentum5
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Shenzhen Transsion Holdings, a mobile phone producer, has a promising long-term outlook according to Smartkarma’s Smart Scores. With strong ratings in Growth, Resilience, and Momentum, the company appears well-positioned for future success. Its high scores in Dividend and Resilience indicate a stable financial position and potential for consistent returns to investors.

Shenzhen Transsion Holdings, known for its global presence in mobile phone markets, continues to show strength in key areas that drive investor confidence. The company’s focus on growth, coupled with solid momentum and resilience, suggests a positive trajectory for its future performance. Investors may find Shenzhen Transsion Holdings an attractive opportunity based on its strong Smart Scores across various factors.

Summary of the company: Shenzhen Transsion Holdings Co., Ltd. is a leader in the production and sale of mobile phones, offering a range of services from research and development to after-sales support. The company’s products are marketed worldwide, showcasing its global reach and influence in the mobile phone industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars